CVS HEALTH CORPORATION Proceeds from Sale and Maturity of Marketable Securities
CVS HEALTH CORPORATION (CVS) reported Proceeds from Sale and Maturity of Marketable Securities of $7.48 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-05
- CVS HEALTH CORPORATION proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-30 was $3.32B, a 0.24% decline year-over-year.
- CVS HEALTH CORPORATION proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-31 was $4.16B, a 17.69% increase year-over-year.
- CVS HEALTH CORPORATION proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $2.74B, a 0.88% increase year-over-year.
- CVS HEALTH CORPORATION proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-30 was $2.77B, a 13.74% decline year-over-year.
- CVS HEALTH CORPORATION proceeds from sale and maturity of marketable securities for fiscal 2025 was $12.38B, a 19.61% increase from fiscal 2024.
- CVS HEALTH CORPORATION proceeds from sale and maturity of marketable securities for fiscal 2024 was $10.35B, a 33.95% increase from fiscal 2023.
- CVS HEALTH CORPORATION proceeds from sale and maturity of marketable securities for fiscal 2023 was $7.73B, a 14.86% increase from fiscal 2022.
- CVS HEALTH CORPORATION proceeds from sale and maturity of marketable securities for fiscal 2022 was $6.73B, a 7.13% decline from fiscal 2021.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.32B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.48B 10-Q · filed 2026-08-05 | $10.23B derived: sum of 3 quarters · filed 2026-08-05 | $13.00B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $4.16B 10-Q · filed 2026-05-06 | $6.90B derived: sum of 2 quarters · filed 2026-05-06 | $9.68B derived: sum of 3 quarters · filed 2026-05-06 | $13.01B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.74B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $5.52B derived: sum of 2 quarters · filed 2026-02-10 | $8.85B derived: sum of 3 quarters · filed 2026-08-05 | $12.38B 10-K · filed 2026-02-10 |
| 2025-09-30 | $2.77B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $6.11B derived: sum of 2 quarters · filed 2026-08-05 | $9.64B 10-Q · filed 2025-10-29 | $12.36B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $3.33B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.87B 10-Q · filed 2026-08-05 | $9.59B derived: sum of 3 quarters · filed 2026-08-05 | $12.80B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $3.53B 10-Q · filed 2026-05-06 | $6.25B derived: sum of 2 quarters · filed 2026-05-06 | $9.47B derived: sum of 3 quarters · filed 2026-05-06 | $11.73B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.72B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $5.93B derived: sum of 2 quarters · filed 2026-02-10 | $8.20B derived: sum of 3 quarters · filed 2026-02-10 | $10.35B 10-K · filed 2026-02-10 |
| 2024-09-30 | $3.22B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $5.48B derived: sum of 2 quarters · filed 2025-10-29 | $7.63B 10-Q · filed 2025-10-29 | $9.82B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $2.27B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $4.42B 10-Q · filed 2025-07-31 | $6.60B derived: sum of 3 quarters · filed 2026-02-10 | $8.51B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $2.15B 10-Q · filed 2025-05-01 | $4.33B derived: sum of 2 quarters · filed 2026-02-10 | $6.24B derived: sum of 3 quarters · filed 2026-02-10 | $7.99B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $2.18B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $4.09B derived: sum of 2 quarters · filed 2026-02-10 | $5.84B derived: sum of 3 quarters · filed 2026-02-10 | $7.73B 10-K · filed 2026-02-10 |
| 2023-09-30 | $1.91B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.66B derived: sum of 2 quarters · filed 2024-11-06 | $5.55B 10-Q · filed 2024-11-06 | $6.74B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $1.75B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $3.64B 10-Q · filed 2024-08-07 | $4.83B derived: sum of 3 quarters · filed 2025-02-12 | $6.01B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $1.89B 10-Q · filed 2024-05-01 | $3.08B derived: sum of 2 quarters · filed 2025-02-12 | $4.26B derived: sum of 3 quarters · filed 2025-02-12 | $6.05B derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $1.19B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $2.37B derived: sum of 2 quarters · filed 2025-02-12 | $4.16B derived: sum of 3 quarters · filed 2025-02-12 | $6.73B 10-K · filed 2025-02-12 |
| 2022-09-30 | $1.18B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $2.96B derived: sum of 2 quarters · filed 2023-11-01 | $5.54B 10-Q · filed 2023-11-01 | $7.22B derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $1.79B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $4.36B 10-Q · filed 2023-08-02 | $6.05B derived: sum of 3 quarters · filed 2024-02-07 | $7.66B derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $2.57B 10-Q · filed 2023-05-03 | $4.26B derived: sum of 2 quarters · filed 2024-02-07 | $5.87B derived: sum of 3 quarters · filed 2024-02-07 | $7.64B derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $1.69B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $3.30B derived: sum of 2 quarters · filed 2024-02-07 | $5.07B derived: sum of 3 quarters · filed 2024-02-07 | $7.25B 10-K · filed 2024-02-07 |
| 2021-09-30 | $1.61B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $3.38B derived: sum of 2 quarters · filed 2022-11-02 | $5.56B 10-Q · filed 2022-11-02 | $8.24B derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-06-30 | $1.77B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $3.95B 10-Q · filed 2022-08-03 | $6.62B derived: sum of 3 quarters · filed 2023-05-25 | $7.70B derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-03-31 | $2.18B 10-Q · filed 2022-05-04 | $4.85B derived: sum of 2 quarters · filed 2023-05-25 | $5.93B derived: sum of 3 quarters · filed 2023-05-25 | $7.36B derived: sum of 4 quarters · filed 2023-05-25 |
| 2020-12-31 | $2.68B derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25 | $3.76B derived: sum of 2 quarters · filed 2023-05-25 | $5.18B derived: sum of 3 quarters · filed 2023-05-25 | $6.47B 8-K · filed 2023-05-25 |
| 2020-09-30 | $1.08B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.50B derived: sum of 2 quarters · filed 2021-11-03 | $3.79B 10-Q · filed 2021-11-03 | $5.22B derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $1.42B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $2.71B 10-Q · filed 2021-08-04 | $4.14B derived: sum of 3 quarters · filed 2022-02-09 | $5.97B derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $1.29B 10-Q · filed 2021-05-04 | $2.72B derived: sum of 2 quarters · filed 2022-02-09 | $4.55B derived: sum of 3 quarters · filed 2022-02-09 | $6.35B derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $3.26B derived: sum of 2 quarters · filed 2022-02-09 | $5.06B derived: sum of 3 quarters · filed 2022-02-09 | $7.05B 10-K · filed 2022-02-09 |
| 2019-09-30 | $1.83B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.63B derived: sum of 2 quarters · filed 2020-11-06 | $5.62B 10-Q · filed 2020-11-06 | $6.39B derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $1.80B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $3.79B 10-Q · filed 2020-08-05 | $4.56B derived: sum of 3 quarters · filed 2021-02-16 | $4.57B derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $1.99B 10-Q · filed 2020-05-06 | $2.76B derived: sum of 2 quarters · filed 2021-02-16 | $2.77B derived: sum of 3 quarters · filed 2021-02-16 | $2.79B derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $774.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $780.00M derived: sum of 2 quarters · filed 2021-02-16 | $807.00M derived: sum of 3 quarters · filed 2021-02-16 | $817.00M 10-K · filed 2021-02-16 |
| 2018-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $33.00M derived: sum of 2 quarters · filed 2019-11-06 | $43.00M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $37.00M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $10.00M 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | $61.00M 10-K · filed 2020-02-18 | |||
| 2016-12-31 | $91.00M 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |